Gotham Therapeutics Company
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.
Headquarters:
New York, New York, United States
Industry:
RNA & Oligonucleotide Medicines
Founded Date:
2017
Funding Status:
Private